I think that logic applies when you are dealing with a mid range product. Given the market A2M are appealing to, I don't think discretionary spending is so much of an issue.
- Forums
- ASX - By Stock
- A2M
- A2M $3 Party
A2M $3 Party, page-198
-
- There are more pages in this discussion • 2,058 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$6.82 |
Change
0.080(1.19%) |
Mkt cap ! $4.919B |
Open | High | Low | Value | Volume |
$6.81 | $6.89 | $6.78 | $2.183M | 319.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 12699 | $6.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.82 | 6924 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 6052 | 6.800 |
9 | 11503 | 6.790 |
12 | 20258 | 6.780 |
8 | 18427 | 6.770 |
6 | 10330 | 6.760 |
Price($) | Vol. | No. |
---|---|---|
6.810 | 2012 | 4 |
6.820 | 6718 | 10 |
6.830 | 19963 | 11 |
6.840 | 29397 | 12 |
6.850 | 8314 | 10 |
Last trade - 10.57am 14/08/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online